Rottenstein Law Group Notes Opposition to Pre-Trial Consolidation of Federal Fosamax Femur Fracture

Rottenstein Law Group Notes Opposition to Pre-Trial Consolidation of Federal Fosamax Femur Fracture Lawsuits The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, is considering the likelihood of consolidation of federal lawsuits against manufacturer Merck for pretrial proceedings in light of recent opposition voiced by some plaintiffs. New York, NY (PRWEB) May 09, 2011 On March 23, 2011, Merck moved the Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federal Fosamax lawsuits into a single Multidistr
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories